Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Complications

By Mayo Clinic staff

Sometimes your efforts to control your pain cause problems.

  • Abdominal problems. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen (Advil, Motrin, others) and aspirin, may cause abdominal pain, bleeding and ulcers — especially if taken in large doses or for a long period of time.
  • Rebound headaches. In addition, if you take over-the-counter or prescription headache medications more than nine days per month or in high doses, you may be setting yourself up for a serious complication known as rebound headaches. Rebound headaches occur when medications not only stop relieving pain, but actually begin to cause headaches. You then use more pain medication, which traps you in a vicious cycle.
  • Serotonin syndrome. This potentially life-threatening drug interaction can occur if you take migraine medicines called triptans, such as sumatriptan (Imitrex) or zolmitriptan (Zomig), along with antidepressants known as selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs). Some common SSRIs include Zoloft, Prozac and Paxil. SNRIs include Cymbalta and Effexor. Fortunately, serotonin syndrome is rare.
Preparing for your appointment Risk factors
References
  1. Silberstein SD. Treatment recommendations for migraine. Nature Clinical Practice Neurology. 2008;4:482.
  2. Wilson JF. In the clinic: Migraine. Annals of Internal Medicine. 2007;147:ITC11-1.
  3. Allais LK, et al. Acupuncture for migraine prophylaxis (review). Hoboken, N.J.: John Wiley & Sons; 2009.
  4. Headache and facial pain. In: Aminoff MJ, et al. Clinical Neurology. 6th ed. New York, N.Y.: McGraw-Hill Companies; 2005. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=66. Accessed April 3, 2009.
  5. Goadsby PJ, et al. Headache. In: Fauci, AS, et al. Harrison's Online. 17th ed. New York, N.Y.: McGraw-Hill Companies; 2008. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=4. Accessed April 3, 2009.
  6. Bajwa ZH, et al. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. http://www.uptodate.com/home/index.html. Accessed March 17, 2009.
  7. Bajwa ZH, et al. Acute treatment of migraine in adults. http://www.uptodate.com/home/index.html. Accessed March 17, 2009.
  8. Bajwa ZH, et al. Preventative treatment of migraine in adults. http://www.uptodate.com/home/index.html. Accessed March 17, 2009.
  9. Trigger avoidance information. American Headache Society. http://www.achenet.org/tools/TriggerAvoidanceInformation.asp. Accessed March 31, 2009.
  10. Migraine. National Headache Foundation. http://www.headaches.org/education/Headache_Topic_Sheets/Migraine. Accessed March 31, 2009.
  11. Hormones and migraines. National Headache Foundation. Accessed March 31, 2009.
  12. Neurological diagnostic tests and procedures. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/misc/diagnostic_tests.htm. Accessed March 31, 2009.
  13. Cruse RP. Pathophysiology, clinical features, and diagnosis of migraine in children. http://www.uptodate.com/home/index.html. Accessed March 17, 2009.
  14. Cruse RP. Classification of migraine in children. http://www.uptodate.com/home/index.html. Accessed March 17, 2009.
  15. Cruse RP. Management of migraine headache in children. http://www.uptodate.com/home/index.html. Accessed March 17, 2009.
  16. Martin VT, et al. Eletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: Results from a multiple-attack study. Cephalagia. 2005;25:726.
  17. Taylor M, et al. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: A pilot study. Headache. 2008;48:1476.
  18. Lawler SP. A randomized, controlled trial of massage therapy as a treatment for migraine. Annals of Behavioral Medicine. 2006;32:50.
  19. FDA public health advisory. U.S. Federal Food and Drug Administration. http://www.fda.gov/cder/drug/advisory/SSRI_SS200607.htm. Accessed March 31, 2009.
  20. Bigal ME. Excessive acute migraine medication use and migraine progression. Neurology. Neurology. 2008;71:1821.
  21. Bigal ME, et al. Advil. Wyeth Consumer Healthcare. http://www.advil.com/products/advil/tablet_label.asp. Accessed April 2, 2009.
  22. Maxalt (prescribing information). Whitehouse Station, N.J.: Merck & Co.; 2008. Accessed April 2, 2009.
  23. Treximet (sumatriptan and naproxen sodium) tablets approved by FDA for acute treatment of migraine. GlaxoSmithKline. http://www.gsk.com/media/pressreleases/2008/2008_us_pressrelease_10034.htm. Accessed April 2, 2009.
  24. Neurontin (prescribing information). New York, N.Y.: Pfizer; 2007. http://www.pfizer.com/products/rx/rx_product_neurontin.jsp. Accessed April 2, 2009.
  25. Acupuncture: An introduction. National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/health/acupuncture/introduction.htm. Accessed April 2, 2009.
  26. Natural product effectiveness checker. Natural Medicines Comprehensive Database. http://www.naturaldatabase.com. Accessed April 2, 2009.
  27. Feverfew. Natural Medicines Comprehensive Database. http://www.naturaldatabase.com. Accessed April 2, 2009.
  28. Butterbur. Natural Medicines Comprehensive Database. http://www.naturaldatabase.com. Accessed April 2, 2009.
  29. Rios J, et al. Evidenced-based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines. Journal of the American Academy of Nurse Practitioners. 2004;16:251.
  30. The dangers of aspirin & NSAIDS. The American College of Gastroenterology. http://www.gi.org/patients/women/asprin.asp. Accessed April 3, 2009.
  31. Fernandez-de-las Penas C, et al. Chronic tension-type headache: What is new? Current Opinion in Neurology. 2009;22:e1. Accessed April 20, 2009.
  32. Swanson JW (expert opinion). Mayo Clinic, Rochester, Minn. April 20, 2009.
  33. Saarto T, et al. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews. 2007:CD005454.
  34. Ninan M, et al. Dynamic optimization of chronic migraine treatment: Current and future options. Neurology. 2009;72(suppl):14.
  35. Olesen J, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalagia. 2006;26:742.

DS00120

June 6, 2009

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger